Distribution of the product will immediately commence. Bupropion Hydrochloride extended-release tablets , available in 300mg strength, are the generic exact carbon copy of Wellbutrin XL for the treatment of main depressive disorder. Annual US sales of brand and generic Wellbutrin XL 300mg were US$581 million for the 12 a few months ending June 2008 regarding to IMS Health data. Commenting on the new approval, Douglas Boothe, CEO of Actavis, Inc. Stated: ‘Bupropion XL compliments our existing Buproprion SR offerings and expands the dosage choices for our customers and patients.